Yoshihiro Nihei
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Pharmacokinetic-guided Management of Foslevodopa/Foscarbidopa infusion in PINK1-related Parkinson's disease with neuropsychiatric vulnerability.
Journal: Clinical parkinsonism & related disorders
Published: May 29, 2026
Clinical and autonomic correlates of chronic Sialorrhea in Parkinson's disease: a questionnaire-based study with cluster analysis of autonomic and dysphagia burden.
Journal: Clinical parkinsonism & related disorders
Published: April 15, 2026
Plasma 3-O-Methyldopa Concentration Monitoring for Treatment Optimization in Foslevodopa/Foscarbidopa Infusion: Implications for Corrected Levodopa Availability: A Case Report.
Journal: Movement disorders clinical practice
Published: April 07, 2026
The characterization of Parkinson's disease related pain based on the classification system: The severity of neuropathic pain and the clinical profile of nociplastic pain.
Journal: Clinical parkinsonism & related disorders
Published: February 01, 2026
Discrepancies in symptom concerns and burden from the perspectives of parkinson's disease patients, caregivers, and physicians.
Journal: Frontiers in neurology
Published: January 22, 2026
Association Between a 1-Year Group-Based Telerehabilitation Program and the Quality of Life of People With Parkinson's Disease: An Observational Study.
Journal: Archives of physical medicine and rehabilitation
Published: September 08, 2025
NDPACX: a newly defined X-linked Parkinsonian syndrome associated with SLC9A6 hemizygote mutation.
Journal: Brain communications
Published: August 07, 2025
Electroconvulsive Therapy Can Prevent a Worsening of Psychosis and Dystonic Voice in PRKN-associated Parkinson's Disease.
Journal: Internal medicine (Tokyo, Japan)
Published: April 29, 2025
Clinical Features of Essential Tremor and its Impact on Quality of Life in Japan.
Journal: Tremor and other hyperkinetic movements (New York, N.Y.)
Published: February 04, 2025
Levodopa Pharmacokinetics in Switching From Levodopa/Carbidopa Intestinal Gel to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in a Patient With Parkinson's Disease: A Case Report.
Journal: Journal of movement disorders
Published: November 28, 2024
Potential Psychosis Induced by a Sustained High Plasma Levodopa Concentration Due to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in a Patient With Parkinson's Disease: A Case Report.
Journal: Journal of movement disorders
Published: May 13, 2024
Satisfaction, effectiveness, and usability of telerehabilitation for Parkinson's disease patients.
Journal: Journal of rehabilitation medicine
Published: January 14, 2024
Last Updated: 09/26/2026